Cardinal Health Stock News

In 2022 high valuations will likely combine with the current Wall of Worry to create increased volatility (and more blue-chip investment opportunities for smart investors). Anti-bubble blue-chip inves

"Dividend Aristocrats in the S&P 500 Index have raised their annual payouts every year for at least 25 consecutive years." - Kiplinger. The 65 Aristocrats screened as of December 23, 2021, represented

We explain why selling the cash-covered puts and covered calls is a safer choice and earns a high income. We will discuss how to formulate an options income strategy that's sustainable and repeatable.

Hartford Investment Management Co. decreased its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 28.9% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 39,957 shares of the companys stock after selling 16,256 shares during the period. Hartford Investment []

DUBLIN--(BUSINESS WIRE)--The "RFID Blood Monitoring System Market Research Report by Device, End-use, and Region - Global Forecast to 2026 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com''s offering. The Global RFID Blood Monitoring System Market size was estimated at USD 459.63 million in 2020, is expected to reach USD 513.56 million in 2021, and projected to grow at a CAGR of 12.07% reaching USD 910.71 million by 2026. Competitive Strategic Window The Competiti

SG Americas Securities LLC raised its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 57.8% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 163,208 shares of the company’s stock after purchasing an additional 59,789 shares during the period. […]

CONSHOHOCKEN, Pa. & DUBLIN, Ohio & IRVING, Texas--(BUSINESS WIRE)--AmerisourceBergen (NYSE: ABC), Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK) announced today that the deadline for political subdivisions in participating states to join the previously announced proposed opioid settlement agreement has been extended from January 2, 2022 to January 26, 2022. Additionally, the state of New Mexico has confirmed its intent to sign on the agreement, increasing the number of participating state

BRESCIA, Italy, Dec. 21, 2021 /PRNewswire/ -- COPAN announces the resolution of its United States International Trade Commission complaint with respondents Cardinal Health, Inc., Innovative Product Brands, Inc., Innovative Product Brands, Inc., KSL Biomedical, Inc., KSL Diagnostics, Inc.,

Watching the developments of the Covid-19 crisis, it could become endemic. Here's what that means for certain stocks to buy.

Key Players Covered in the Long Term Care Technology Market Research Report Are Medline Industries Inc. (U.S.), Medtronic (Ireland), B. Braun Melsungen AG (Germany), 3M (U.S.), Baxter (U.S.), ARKRAY Inc. (Japan), BD (U.S.), Omron Healthcare Inc. (Japan), Koninklijke Philips N.V. (Netherlands), GENERAL ELECTRIC COMPANY (U.S.), Fresenius Medical Care AG & Co. KGaA (Germany), Cardinal Health (U.S.), Boston Scientific Corporation (U.S.), Honeywell International Inc. (U.S.) and other key market players. Key Players Covered in the Long Term Care Technology Market Research Report Are Medline Industries Inc. (U.S.), Medtronic (Ireland), B. Braun Melsungen AG (Germany), 3M (U.S.), Baxter (U.S.), ARKRAY Inc. (Japan), BD (U.S.), Omron Healthcare Inc. (Japan), Koninklijke Philips N.V. (Netherlands), GENERAL ELECTRIC COMPANY (U.S.), Fresenius Medical Care AG & Co. KGaA (Germany), Cardinal Health (U.S.), Boston Scientific Corporation (U.S.), Honeywell International Inc. (U.S.) and other key market players.

Equities research analysts forecast that Cardinal Health, Inc. (NYSE:CAH) will announce $44.62 billion in sales for the current quarter, according to Zacks Investment Research. Three analysts have issued estimates for Cardinal Healths earnings, with the lowest sales estimate coming in at $44.30 billion and the highest estimate coming in at $45.26 billion. Cardinal Health posted []

Morgan Stanley grew its position in Cardinal Health, Inc. (NYSE:CAH) by 46.8% in the second quarter, Holdings Channel reports. The fund owned 2,020,207 shares of the companys stock after acquiring an additional 643,723 shares during the quarter. Morgan Stanleys holdings in Cardinal Health were worth $115,333,000 at the end of the most recent reporting period. []

Cardinal Health (NYSE:CAH) had its price target lowered by investment analysts at Morgan Stanley from $64.00 to $54.00 in a research note issued to investors on Friday, Price Targets.com reports. The firm currently has an equal weight rating on the stock. Morgan Stanleys price target points to a potential upside of 8.76% from the stocks []

Wall Street analysts expect that Cardinal Health, Inc. (NYSE:CAH) will post $1.40 earnings per share (EPS) for the current fiscal quarter, Zacks reports. Three analysts have provided estimates for Cardinal Healths earnings. The lowest EPS estimate is $1.31 and the highest is $1.58. Cardinal Health posted earnings per share of $1.74 in the same quarter []